|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 I STREET, NW |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3173-12
|
||||||||
|
6. House ID# 333530000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: SUSAN POLAN |
Date | 7/19/2017 9:19:57 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Increase funding for the Centers for Disease Control and Prevention in FY 2017 and FY 2018.
Increase funding for the Health Resources and Services Administration in FY 2017 and FY 2018.
Support of full funding for HRSAs health professions and nursing workforce development programs in fiscal year 2018.
Support adequate funding for the National Health Service Corps.
Support adequate FY 2018 funding for the Agency for Healthcare Research and Quality.
Oppose appropriations riders to block or delay FDA regulation of tobacco products.
Oppose cuts to CDC's Office of Smoking and Health.
Oppose appropriations riders to weaken Clean Air Act regulations.
Support ample funding to combat the Zika virus in the Fiscal Year 2018 appropriations bills.
Oppose cuts and supporting adequate funding for NDD programs in the FY 2018 appropriations process.
Support adequate FY 2018 funding for the National Center for Health Statistics.
Support adequate FY 2018 funding for CDC's National Center for Chronic Disease Prevention and Health Promotion.
Support adequate FY 2018 funding for WIC.
Proposed recommendations for a public health emergency response fund if included in the FY2018 Labor-Health and Human Services and Education Appropriations bill.
Urge appropriators to support strong FDA oversight and enforcement of the 2013 Drug Quality and Security Act.
Urge House and Senate Budget Committees to maintain strong investments in HHS global health programs.
Support strong funding for the Office of National Drug Control Policy.
Strong funding for programs critical to public health preparedness.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Nicole |
Burda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Oppose any effort to exempt cigars from regulation under the Tobacco Control Act.
Oppose H.R. 1136, the FDA Deeming Authority Clarification Act.
Support H.R. 1662 to prohibit smoking in any facility of the Veterans Health Administration.
Support full implementation of deeming rule without delays.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Oppose the American Health Care Act.
Oppose the Better Care Reconciliation Act.
Oppose efforts to repeal the Affordable Care Act.
Oppose efforts to repeal the Prevention and Public Health Fund.
Oppose efforts to cap or block grant Medicaid and end the Medicaid expansion under the Affordable Care Act.
Oppose any effort to condition payment for health care services on factors other than medical and legal qualifications and standards.
Support strong U.S. leadership at the United Nations, including by fully meeting our nations financial obligations to the organization.
Support comprehensive over-the-counter monograph reform efforts.
Support the the Save Women's Preventive Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), White House Office, President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
|
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Support the Professional's Access to Health Workforce Integration Act of 2017 to authorize grants for career support for skilled, internationally educated health professionals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
|
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Oppose H.R. 5 and S. 951, the Regulatory Accountability Act of 2017.
Oppose the Regulations from the Executive in Need of Scrutiny, or REINS, Act and the Midnight Rules Relief Act.
Oppose H.R. 998, the SCRUB Act; H.R. 1004, the Regulatory Integrity Act; and H.R. 1009, the OIRA Insight, Reform, and Accountability Act.
Oppose the EPA Science Advisory Board Reform Act of 2017 and the Honest and Open New EPA Science Treatment Act of 2017.
Oppose H.J. Res. 36, a resolution of disapproval using the Congressional Review Act to permanently the Bureau of Land Management from reducing methane leaks from the oil and gas industries.
Oppose the Ozone Standards Implementation Act of 2016.Office of Management and Budget raising Oppose executive order 13771 Reducing Regulation and Controlling Regulatory Costs over concerns that it could jeopardize public regulations that safeguard safety and health.
Oppose the Ozone Standards Implementation Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Support for the Office of National Drug Control Policy.
Expressed concern that the American Health Care Act would result in reductions in care for people suffering from addiction and mental illness.
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Support nutrition facts label compliance date.
Oppose S. 261 and H.R. 772, the Common Sense Nutrition Disclosure Act of 2017, legislation that would weaken menu labeling regulations.
Support Food and Drug Administration moving forward with voluntary sodium reduction targets for the food manufacturing industry.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), U.S. SENATE, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Oppose H.J.Res. 43 and S.J.Res. 13, legislation that would would overturn the U.S.
Department of Health and Human Services final rule updating the regulations that apply to the Title X Family Planning Program.
Oppose any effort to exclude Planned Parenthood health centers from participating in federal health programs.
Urge the Office of Management and Budget to support family planning and sexual health care services in its FY 2018 budget request.
Support a strong national paid family and medical leave policy.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Nicole |
Burda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |